Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Regeneron (REGN)

NASDAQ:REGN

US Market

REGN

Regeneron

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Regeneron (REGN) Stock News & Sentiment

4,760 Followers

Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis

Company Announcements

Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis

16h ago

Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game Changer for Chronic Rhinosinusitis

Company Announcements

Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game Changer for Chronic Rhinosinusitis

16h ago

Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Market Game-Changer?

Company Announcements

Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Market Game-Changer?

16h ago

Regeneron’s Long-Term Melanoma Study: Key Insights for Investors

Company Announcements

Regeneron’s Long-Term Melanoma Study: Key Insights for Investors

16h ago

Regeneron’s Promising Study on Odronextamab for B-cell Non-Hodgkin Lymphoma

Company Announcements

Regeneron’s Promising Study on Odronextamab for B-cell Non-Hodgkin Lymphoma

16h ago

Regeneron’s Promising Obesity Treatment Study: A Potential Game-Changer?

Company Announcements

Regeneron’s Promising Obesity Treatment Study: A Potential Game-Changer?

16h ago

QQQ ETF News, 7/17/2025

Market News

QQQ ETF News, 7/17/2025

21h ago

More REGN News >

REGN News on the Web

2025-07-16

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

CNBC

Neutral

2025-07-16

BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?

Zacks

Neutral

2025-07-11

QQQ ETF News, 7/11/2025

TipRanks News

Neutral

2025-07-08

QQQ ETF News, 7/8/2025

TipRanks News

Neutral

2025-07-08

Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), Regeneron (REGN)

TipRanks News

Neutral

2025-07-07

Intellia Gains 29.8% in a Month: How Should You Play the Stock?

Zacks

Neutral

2025-07-05

2 Beaten-Down Stocks to Buy and Hold

The Motley Fool

Neutral

2025-07-03

FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug

Zacks

Neutral

News Score - Last 7 Days

Neutral

REGN

Sector Average

Media Buzz

This Week4 articles

Weekly Average5.25 articles

News Sentiment

This Week59%

Sector Average56%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?

4 articles about REGN were published this week. In an average week, 5.25 articles are published.

What is REGN’s weekly average amount of articles?

In an average week, 5.25 articles about REGN are published.

What is REGN’s News Sentiment?

59% of articles about REGN were positive this week, compared to its sector average of 56%.

Healthcare Stocks that are Trending in the News

NEVIPascal Biosciences Inc

HRMYHarmony Biosciences Holdings

JNJJohnson & Johnson

WATWaters

NNVCNanoViricides

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing